Indomira is a U.S. and New Zealand-based phytopharmaceutical company dedicated to unlocking the healing potential of medical Cannabis. We are developing clinically-proven medicines that enhance everyday health, provide preventive strategies, and address modern conditions.  As prohibition gives way to changing sentiment, an unprecedented wave of research is validating the efficacy of Cannabis as a medical treatment and a wellness therapy. This is providing hope and solutions for managing conditions such as cancer, chronic pain, epilepsy, and multiple sclerosis. However, more work is needed to build the scientific framework for safe and effective use, educate healthcare professionals, and change public awareness. This is at the heart of our mission. Through research, education, and knowledge-sharing, we’re inspiring new thinking and informed decisions about Cannabis and health.